Evidence map›Paper›PMID 29926732›Full record

ArticleAIDS research and human retroviruses2018

Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.

Amanda B Macedo, Rachel S Resop, Laura J Martins, Matthew A Szaniawski, Eric S Sorensen, Adam M Spivak, Douglas F Nixon, R Brad Jones, Vicente Planelles, Alberto Bosque

Open access · bronzeAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Cultured TMethods in molecular biology (Clifton, N.J.) · 2022
    Article
  7. Review
  8. Selective BCL-XJournal of virology · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Sexual dimorphism in HIV-1 infection.Seminars in immunopathology · 2019
    Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Amanda B Macedo1 Department of Microbiology, Immunology, and Tropical Medicine, School of Medicine and Health Sciences, George Washington University , Washington, District of Columbia.
Rachel S Resop1 Department of Microbiology, Immunology, and Tropical Medicine, School of Medicine and Health Sciences, George Washington University , Washington, District of Columbia.
Laura J Martins2 Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine , Salt Lake City, Utah.
Matthew A Szaniawski2 Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine , Salt Lake City, Utah.
Eric S Sorensen1 Department of Microbiology, Immunology, and Tropical Medicine, School of Medicine and Health Sciences, George Washington University , Washington, District of Columbia.
Adam M Spivak3 Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine , Salt Lake City, Utah.
Douglas F Nixon1 Department of Microbiology, Immunology, and Tropical Medicine, School of Medicine and Health Sciences, George Washington University , Washington, District of Columbia.
R Brad Jones1 Department of Microbiology, Immunology, and Tropical Medicine, School of Medicine and Health Sciences, George Washington University , Washington, District of Columbia.
Vicente Planelles2 Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine , Salt Lake City, Utah.
Alberto Bosque1 Department of Microbiology, Immunology, and Tropical Medicine, School of Medicine and Health Sciences, George Washington University , Washington, District of Columbia.
University of Utah · US

Funding

SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Italo Mocchetti · 2015 to 2026
$29.6M
BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral EradicationUM1AI126617 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI JONES, R. BRAD, NIXON, DOUGLAS F · 2016 to 2020
$28.1M
Developing Pathogen Recognition Receptor Agonists as Latency Reversing AgentsR01AI124722 · NIAID · UNIVERSITY OF UTAH · PI BOSQUE, ALBERTO · 2016 to 2020
$2.1M
A family of compounds that reactivate latent HIV without T cell activationR33AI116212 · NIAID · UNIVERSITY OF UTAH · PI BOSQUE, ALBERTO · 2016 to 2018
$1.4M
A family of compounds that reactivate latent HIV without T cell activationR21AI116212 · NIAID · UNIVERSITY OF UTAH · PI BOSQUE, ALBERTO · 2014 to 2015
$349k
NIAID NIH HHS P30 AI117970NIAID NIH HHS R01 AI124722NIAID NIH HHS R21 AI116212NIAID NIH HHS R33 AI116212NIAID NIH HHS UM1 AI126617
6 · The paper itself

Abstract

Primary cell models of human immunodeficiency virus (HIV) latency have become tools to both understand the mechanisms involved in establishment of latency and test preclinical strategies toward HIV-1 cure. These models rely on infection of CD4 T cells from healthy donors. As such, these models provide an opportunity to explore the role of biological sex, age, and HIV status on establishment and reactivation of latent HIV in vitro. We have used an established primary cell model of latency based on the generation of latently infected central memory CD4 T cells with the CXCR4 strain HIV-1

Indexed as

AdolescentAdultAgedAge FactorsCD4-Positive T-LymphocytesCells, CulturedFemaleHIV-1HIV InfectionsHumansMaleMiddle AgedPrimary Cell CultureReceptors, CXCR4Sex FactorsSignal TransductionCXCR4 protein, humanReceptors, CXCR4agebiological sexHIVlatencyprimary cell modelsreservoirs

Identifiers

PMID29926732
PMCPMC6152854
OpenAlexW2808915156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.